Book contents
- Managing the Menopause
- Managing the Menopause
- Copyright page
- Contents
- Contributors
- Foreword
- Chapter 1 Physiology of the Menstrual Cycle and Changes in the Perimenopause
- Chapter 2 Clinical Features of the Menopause/Postmenopause
- Chapter 3 The Ovarian Reserve
- Chapter 4 Premature Ovarian Insufficiency
- Chapter 5 Premature Ovarian Insufficiency
- Chapter 6 Natural Hormone Replacement Therapy after Menopause by Ovarian Tissue Transplantation
- Chapter 7 Migraine in the Menopause
- Chapter 8 Psychological Aspects of the Menopause
- Chapter 9 Memory and Mood in the Menopause
- Chapter 10 Libido and Sexual Function in the Menopause
- Chapter 11 Vulvo-Vaginal Atrophy (VVA)
- Chapter 12 Pelvic Floor, Urinary Problems and the Menopause
- Chapter 13 The Effect of Menopause on the Musculoskeletal System
- Chapter 14 Hormonal Management of Osteoporosis during the Menopause
- Chapter 15 Cardiovascular Disease and the Menopause
- Chapter 16 Gynecological Pathology in the Menopause (Excluding Cancers)
- Chapter 17 Nutrition and Weight Gain in the Menopause
- Chapter 18 The Use of Estrogens and Progestogens in Menopausal Hormone Therapy
- Chapter 19 Androgen Therapy for Postmenopausal Women
- Cahpter 20 Contraception for the Perimenopausal Woman
- Chapter 21 Hormone Therapy and Cancer
- Chapter 22 Menopausal Hormone Therapy (MHT) and Venous Thrombosis
- Chapter 23 The Risk–Benefit Analysis of Menopausal Hormone Therapy in the Menopause
- Chapter 24 Selective Estrogen Receptor Modulators (SERMs) and Menopausal Hormone Therapy (MHT)
- Chapter 25 Non-hormonal Treatments for Menopausal Symptoms
- Chapter 26 Alternative Therapies for the Management of Menopausal Symptoms
- Chapter 27 Menopause in Primary Care
- Index
- References
Chapter 4 - Premature Ovarian Insufficiency
Fertility Options
Published online by Cambridge University Press: 18 June 2020
- Managing the Menopause
- Managing the Menopause
- Copyright page
- Contents
- Contributors
- Foreword
- Chapter 1 Physiology of the Menstrual Cycle and Changes in the Perimenopause
- Chapter 2 Clinical Features of the Menopause/Postmenopause
- Chapter 3 The Ovarian Reserve
- Chapter 4 Premature Ovarian Insufficiency
- Chapter 5 Premature Ovarian Insufficiency
- Chapter 6 Natural Hormone Replacement Therapy after Menopause by Ovarian Tissue Transplantation
- Chapter 7 Migraine in the Menopause
- Chapter 8 Psychological Aspects of the Menopause
- Chapter 9 Memory and Mood in the Menopause
- Chapter 10 Libido and Sexual Function in the Menopause
- Chapter 11 Vulvo-Vaginal Atrophy (VVA)
- Chapter 12 Pelvic Floor, Urinary Problems and the Menopause
- Chapter 13 The Effect of Menopause on the Musculoskeletal System
- Chapter 14 Hormonal Management of Osteoporosis during the Menopause
- Chapter 15 Cardiovascular Disease and the Menopause
- Chapter 16 Gynecological Pathology in the Menopause (Excluding Cancers)
- Chapter 17 Nutrition and Weight Gain in the Menopause
- Chapter 18 The Use of Estrogens and Progestogens in Menopausal Hormone Therapy
- Chapter 19 Androgen Therapy for Postmenopausal Women
- Cahpter 20 Contraception for the Perimenopausal Woman
- Chapter 21 Hormone Therapy and Cancer
- Chapter 22 Menopausal Hormone Therapy (MHT) and Venous Thrombosis
- Chapter 23 The Risk–Benefit Analysis of Menopausal Hormone Therapy in the Menopause
- Chapter 24 Selective Estrogen Receptor Modulators (SERMs) and Menopausal Hormone Therapy (MHT)
- Chapter 25 Non-hormonal Treatments for Menopausal Symptoms
- Chapter 26 Alternative Therapies for the Management of Menopausal Symptoms
- Chapter 27 Menopause in Primary Care
- Index
- References
Summary
Although in vitro fertilization (IVF) was developed for the treatment of tubal infertility, [1], it soon became apparent that human IVF had many other applications such as male factor subfertility [2], unexplained subfertility [3] and restoring fertility in women without functioning ovaries using ovum [4] or embryo donation. Although ovum donation was originally used to treat women with Turner’s syndrome [5], it has also been successfully applied to women with other causes of premature ovarian insufficiency (POI) over the last 35 years. The concept of gamete donation is not new, with sperm donation (DI) having been utilized, initially with fresh sperm and subsequently with stored frozen sperm for several decades [6]. In DI the woman’s partner becomes the social father but is not the genetic father, whereas in oocyte donation the woman who has the child is the birth and social mother, but not the genetic mother. Although the child is not directly genetically linked, egg donation allows the patient to carry and deliver her husband’s genetic child.
- Type
- Chapter
- Information
- Managing the Menopause , pp. 28 - 37Publisher: Cambridge University PressPrint publication year: 2020